Stockreport

Altamira Therapeutics Announces Pricing of up to $12.0 Million Public Offering

Altamira Therapeutics Ltd. - Common Shares  (CYTO) 
PDF Hamilton, Bermuda, Sept. 17, 2024 (GLOBE NEWSWIRE) -- $4 million upfront with up to an additional $8 million of aggregate gross proceeds upon the exercise in full for [Read more]